Search

everythinglearnresearchcommunity

for

Search:↓

Dermatologists should carefully choose treatments for FFA to avoid worsening the condition.

Intralesional triamcinolone injections can effectively stop frontal fibrosing alopecia with minimal side effects.

Tebentafusp-tebn improves survival rates in uveal melanoma patients but has common side effects like rash and fatigue.

Formalin-induced pain increases testosterone breakdown in the rat brain and spinal cord.

Thermal imaging is a useful non-invasive method to diagnose active inflammation in frontal fibrosing alopecia.

HPT axis hormones boost mitochondrial function and growth in hair follicles, potentially aiding hair health.

A new nanozyme using EGCG and L-arginine boosts hair growth by safely increasing beneficial oxidative stress.

Melatonin may treat rosacea and Alzheimer's by reducing inflammation and affecting blood vessel growth.

Tofacitinib may effectively treat skin symptoms in difficult cases of dermatomyositis.

Early combination therapy can effectively regrow hair in frontal fibrosing alopecia.

Temporal triangular alopecia is a lifelong condition with hairless patches on the side of the head that may be present from birth.

Some patients on anti-TNF drugs experience a type of hair loss called TAIAPA.

Tofacitinib effectively treated both ulcerative colitis and alopecia areata in two patients.

FFA is more common in postmenopausal women, can affect younger women, and may stabilize over time.

TAF can be identified by excessive skin thickening and clogged hair follicles, helping distinguish it from similar skin conditions.

Thermus thermophilus extract improves hair growth and scalp health in men with hair loss.

Tofacitinib is a potential alternative treatment for alopecia totalis, especially in patients with a shorter duration of the condition and more preserved hair follicles, but the overall response rate is low.

Applying 2% tofacitinib cream helped some children with severe hair loss grow back hair.

Most cases of Temporal Triangular Alopecia are found in early childhood and may be related to genetic conditions.

The trial showed that a new under-the-tongue treatment for severe hair loss was somewhat effective in a small group of people.

Experts agreed on guidelines to improve research on Frontal Fibrosing Alopecia.

Tofacitinib works better and is more tolerable for severe alopecia than conventional treatments and DPCP immunotherapy.

Oral tofacitinib successfully treated a girl's severe skin and hair conditions.

Frontal fibrosing alopecia is a scarring hair loss condition mainly affecting older women, with no known cause and treatments that may help stabilize hair loss.

Tofacitinib can regrow hair in alopecia areata patients, but some may experience flares during treatment.

Tremella fuciformis polysaccharide has many health benefits and potential uses in food, medicine, and cosmetics.

FFA's causes may include environmental triggers and genetic factors.

Hair transplant surgery effectively treated a specific type of hair loss and is recommended as a primary treatment option.

The T-Fast multi-implanter makes hair transplant surgeries quicker and cheaper.

Frontal fibrosing alopecia is a challenging hair loss condition with no known cause or definitive treatment.